Fletcher R John
SEC-identified person · CIK 1215024 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| MRI Interventions, INC. None | Director | filed 2017–2026 |
| Repro MED Systems INC repr | Director | filed 2019–2026 |
| Optinose, Inc. OPTN | Director | filed 2022–2025 |
| Vyant Bio, Inc. VYNT | Director | filed 2021–2023 |
| Axcelis Technologies INC ACLS | Director | filed 2006–2021 |
| Spectranetics Corp SPNC | Director | filed 2007–2017 |
| Nastech Pharmaceutical CO INC NSTK | Director | filed 2011–2011 |
| Autoimmune INC AIMM | Director | filed 2006–2009 |
| Panacos Pharmaceuticals, INC. PANC | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.